Afficher la notice abrégée

dc.contributor.authorUgurlu, Ali Seyhan*
dc.date.accessioned2021-02-11T09:07:55Z
dc.date.available2021-02-11T09:07:55Z
dc.date.issued2014*
dc.date.submitted2018-11-05 12:58:39*
dc.identifier29446*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/42178
dc.description.abstractThe topic of this book is one of the most contentious, complex and at the same time very important in many respects. Latest achievements in the biotechnology industry related to the stem cell technology are quite important.*
dc.languageEnglish*
dc.relation.ispartofseriesMunich Intellectual Property Law Center - MIPLC*
dc.subjectK1-7720*
dc.subject.classificationbic Book Industry Communication::L Lawen_US
dc.subject.otherMarkenrecht*
dc.subject.otherUrheberrecht / Gewerblicher Rechtsschutz und Medienrecht*
dc.subject.otherUgurlu*
dc.subject.otherGewerblicher Rechtsschutz*
dc.titleBioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe*
dc.typebook
oapen.identifier.doihttp://dx.doi.org/10.5771/9783845255149*
oapen.relation.isPublishedBy20c8b06d-3b2b-4af2-acda-fbcfdfea5744*
oapen.relation.isbn9783845255149*
oapen.volume22*
oapen.edition1*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/